What is Actoprobe?
Founded in 2009 and headquartered in Albuquerque, New Mexico, Actoprobe has established itself as a critical player in the precision measurement sector. The company designs and manufactures sophisticated optical spectroscopy and microscopy tools that enable researchers and industrial engineers to perform high-resolution scanning probe microscopy. By bridging the gap between complex laboratory research and scalable industrial application, Actoprobe provides the essential hardware infrastructure required for nanotechnology, materials science, and semiconductor quality control. Their market position is defined by a commitment to high-fidelity imaging and analytical precision, serving a niche yet vital segment of the global scientific instrumentation market.
How much funding has Actoprobe raised?
Actoprobe has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
Key Investors in Actoprobe
PPP
Public-Private Partnership
What's next for Actoprobe?
With the recent influx of capital, Actoprobe is strategically positioned to accelerate its product development roadmap and expand its commercial footprint. The current Series B/C stage indicates a shift from foundational R&D toward aggressive market penetration and operational scaling. Future initiatives will likely focus on enhancing the throughput of their scanning probe systems and diversifying their portfolio to address emerging demands in quantum materials and advanced electronics manufacturing. By leveraging this financial backing, the company aims to solidify its competitive advantage, ensuring that its proprietary optical technologies remain at the forefront of the microscopy industry as it navigates the complexities of global supply chains and increasing demand for high-precision analytical tools.
See full Actoprobe company page
